These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 27402876)
1. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Wyszynski A; Hong CC; Lam K; Michailidou K; Lytle C; Yao S; Zhang Y; Bolla MK; Wang Q; Dennis J; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Peto J; Dos-Santos-Silva I; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Nordestgaard BG; González-Neira A; Benitez J; Neuhausen SL; Brenner H; Dieffenbach AK; Meindl A; Schmutzler RK; Brauch H; ; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; ; Wu AH; Van Den Berg D; Lambrechts D; Wildiers H; Chang-Claude J; Rudolph A; Radice P; Peterlongo P; Couch FJ; Olson JE; Giles GG; Milne RL; Haiman CA; Henderson BE; Dumont M; Teo SH; Wong TY; Kristensen V; Zheng W; Long J; Winqvist R; Pylkäs K; Andrulis IL; Knight JA; Devilee P; Seynaeve C; García-Closas M; Figueroa J; Klevebring D; Czene K; Hooning MJ; van den Ouweland AM; Darabi H; Shu XO; Gao YT; Cox A; Blot W; Signorello LB; Shah M; Kang D; Choi JY; Hartman M; Miao H; Hamann U; Jakubowska A; Lubinski J; Sangrajrang S; McKay J; Toland AE; Yannoukakos D; Shen CY; Wu PE; Swerdlow A; Orr N; Simard J; Pharoah PD; Dunning AM; Chenevix-Trench G; Hall P; Bandera E; Amos C; Ambrosone C; Easton DF; Cole MD Hum Mol Genet; 2016 Sep; 25(17):3863-3876. PubMed ID: 27402876 [TBL] [Abstract][Full Text] [Related]
2. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Ghoussaini M; Edwards SL; Michailidou K; Nord S; Cowper-Sal Lari R; Desai K; Kar S; Hillman KM; Kaufmann S; Glubb DM; Beesley J; Dennis J; Bolla MK; Wang Q; Dicks E; Guo Q; Schmidt MK; Shah M; Luben R; Brown J; Czene K; Darabi H; Eriksson M; Klevebring D; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Lambrechts D; Thienpont B; Neven P; Wildiers H; Broeks A; Van't Veer LJ; Th Rutgers EJ; Couch FJ; Olson JE; Hallberg E; Vachon C; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Peto J; Dos-Santos-Silva I; Gibson L; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Hall P; Li J; Liu J; Humphreys K; Kang D; Choi JY; Park SK; Noh DY; Matsuo K; Ito H; Iwata H; Yatabe Y; Guénel P; Truong T; Menegaux F; Sanchez M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Benitez J; Zamora MP; Perez JI; Menéndez P; Shu XO; Lu W; Gao YT; Cai Q; Cox A; Cross SS; Reed MW; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Lindblom A; Margolin S; Teo SH; Yip CH; Lee DS; Wong TY; Hooning MJ; Martens JW; Collée JM; van Deurzen CH; Hopper JL; Southey MC; Tsimiklis H; Kapuscinski MK; Shen CY; Wu PE; Yu JC; Chen ST; Alnæs GG; Borresen-Dale AL; Giles GG; Milne RL; McLean C; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Hartman M; Miao H; Buhari SA; Teo YY; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Simard J; Goldberg MS; Labrèche F; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Brauch H; Brüning T; Koto YD; Radice P; Peterlongo P; Bonanni B; Volorio S; Dörk T; Bogdanova NV; Helbig S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Slager S; Toland AE; Ambrosone CB; Yannoukakos D; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Hamann U; Torres D; Zheng W; Long J; Anton-Culver H; Neuhausen SL; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; González-Neira A; Pita G; Alonso MR; Alvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; de Santiago I; Carroll J; Caldas C; Brown MA; Lupien M; Kristensen VN; Pharoah PD; Chenevix-Trench G; French JD; Easton DF; Dunning AM; ; Nat Commun; 2014 Sep; 4():4999. PubMed ID: 25248036 [TBL] [Abstract][Full Text] [Related]
3. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. Baxter JS; Johnson N; Tomczyk K; Gillespie A; Maguire S; Brough R; Fachal L; Michailidou K; Bolla MK; Wang Q; Dennis J; Ahearn TU; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Augustinsson A; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bogdanova NV; Bojesen SE; Brenner H; Brucker SY; Cai Q; Campa D; Canzian F; Castelao JE; Chan TL; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Choi JY; Clarke CL; ; Colonna S; Conroy DM; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dossus L; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Engel C; Fasching PA; Figueroa J; Flyger H; Gago-Dominguez M; Gao C; García-Closas M; García-Sáenz JA; Ghoussaini M; Giles GG; Goldberg MS; González-Neira A; Guénel P; Gündert M; Haeberle L; Hahnen E; Haiman CA; Hall P; Hamann U; Hartman M; Hatse S; Hauke J; Hollestelle A; Hoppe R; Hopper JL; Hou MF; ; ; Ito H; Iwasaki M; Jager A; Jakubowska A; Janni W; John EM; Joseph V; Jung A; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kosma VM; Kraft P; Kristensen VN; Kubelka-Sabit K; Kurian AW; Kwong A; Lacey JV; Lambrechts D; Larson NL; Larsson SC; Le Marchand L; Lejbkowicz F; Li J; Long J; Lophatananon A; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Matsuo K; Mavroudis D; Mayes R; Menon U; Milne RL; Mohd Taib NA; Muir K; Muranen TA; Murphy RA; Nevanlinna H; O'Brien KM; Offit K; Olson JE; Olsson H; Park SK; Park-Simon TW; Patel AV; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Pylkäs K; Rack B; Rennert G; Romero A; Ruebner M; Rüdiger T; Saloustros E; Sandler DP; Sawyer EJ; Schmidt MK; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Shah M; Shen CY; Shu XO; Simard J; Southey MC; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Taylor JA; Teo SH; Teras LR; Terry MB; Toland AE; Tomlinson I; Truong T; Tseng CC; Untch M; Vachon CM; van den Ouweland AMW; Wang SS; Weinberg CR; Wendt C; Winham SJ; Winqvist R; Wolk A; Wu AH; Yamaji T; Zheng W; Ziogas A; Pharoah PDP; Dunning AM; Easton DF; Pettitt SJ; Lord CJ; Haider S; Orr N; Fletcher O Am J Hum Genet; 2021 Jul; 108(7):1190-1203. PubMed ID: 34146516 [TBL] [Abstract][Full Text] [Related]
4. Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent. Garner CP; Ding YC; John EM; Ingles SA; Olopade OI; Huo D; Adebamowo C; Ogundiran T; Neuhausen SL Hum Genet; 2008 Apr; 123(3):247-55. PubMed ID: 18210156 [TBL] [Abstract][Full Text] [Related]
5. Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men. Orr N; Cooke R; Jones M; Fletcher O; Dudbridge F; Chilcott-Burns S; Tomczyk K; Broderick P; Houlston R; Ashworth A; Swerdlow A PLoS Genet; 2011 Sep; 7(9):e1002290. PubMed ID: 21949660 [TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians. Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer. Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734 [TBL] [Abstract][Full Text] [Related]
9. Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C. Dryden NH; Broome LR; Dudbridge F; Johnson N; Orr N; Schoenfelder S; Nagano T; Andrews S; Wingett S; Kozarewa I; Assiotis I; Fenwick K; Maguire SL; Campbell J; Natrajan R; Lambros M; Perrakis E; Ashworth A; Fraser P; Fletcher O Genome Res; 2014 Nov; 24(11):1854-68. PubMed ID: 25122612 [TBL] [Abstract][Full Text] [Related]
10. Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies. Huang T; Hong J; Lin W; Yang Q; Ni K; Wu Q; Sun J PLoS One; 2013; 8(8):e69056. PubMed ID: 23976942 [TBL] [Abstract][Full Text] [Related]
11. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Stacey SN; Manolescu A; Sulem P; Rafnar T; Gudmundsson J; Gudjonsson SA; Masson G; Jakobsdottir M; Thorlacius S; Helgason A; Aben KK; Strobbe LJ; Albers-Akkers MT; Swinkels DW; Henderson BE; Kolonel LN; Le Marchand L; Millastre E; Andres R; Godino J; Garcia-Prats MD; Polo E; Tres A; Mouy M; Saemundsdottir J; Backman VM; Gudmundsson L; Kristjansson K; Bergthorsson JT; Kostic J; Frigge ML; Geller F; Gudbjartsson D; Sigurdsson H; Jonsdottir T; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Jonsson T; von Holst S; Werelius B; Margolin S; Lindblom A; Mayordomo JI; Haiman CA; Kiemeney LA; Johannsson OT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K Nat Genet; 2007 Jul; 39(7):865-9. PubMed ID: 17529974 [TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of 2q35-rs13387042 polymorphism and hormone receptor status with breast cancer risk. Gu C; Zhou L; Yu J PLoS One; 2013; 8(7):e66979. PubMed ID: 23894282 [TBL] [Abstract][Full Text] [Related]
13. Biological effects and regulation of IGFBP5 in breast cancer. Dittmer J Front Endocrinol (Lausanne); 2022; 13():983793. PubMed ID: 36093095 [TBL] [Abstract][Full Text] [Related]
14. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF; J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422 [TBL] [Abstract][Full Text] [Related]
15. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Zeng C; Guo X; Long J; Kuchenbaecker KB; Droit A; Michailidou K; Ghoussaini M; Kar S; Freeman A; Hopper JL; Milne RL; Bolla MK; Wang Q; Dennis J; Agata S; Ahmed S; Aittomäki K; Andrulis IL; Anton-Culver H; Antonenkova NN; Arason A; Arndt V; Arun BK; Arver B; Bacot F; Barrowdale D; Baynes C; Beeghly-Fadiel A; Benitez J; Bermisheva M; Blomqvist C; Blot WJ; Bogdanova NV; Bojesen SE; Bonanni B; Borresen-Dale AL; Brand JS; Brauch H; Brennan P; Brenner H; Broeks A; Brüning T; Burwinkel B; Buys SS; Cai Q; Caldes T; Campbell I; Carpenter J; Chang-Claude J; Choi JY; Claes KB; Clarke C; Cox A; Cross SS; Czene K; Daly MB; de la Hoya M; De Leeneer K; Devilee P; Diez O; Domchek SM; Doody M; Dorfling CM; Dörk T; Dos-Santos-Silva I; Dumont M; Dwek M; Dworniczak B; Egan K; Eilber U; Einbeigi Z; Ejlertsen B; Ellis S; Frost D; Lalloo F; ; Fasching PA; Figueroa J; Flyger H; Friedlander M; Friedman E; Gambino G; Gao YT; Garber J; García-Closas M; Gehrig A; Damiola F; Lesueur F; Mazoyer S; Stoppa-Lyonnet D; ; Giles GG; Godwin AK; Goldgar DE; González-Neira A; Greene MH; Guénel P; Haeberle L; Haiman CA; Hallberg E; Hamann U; Hansen TV; Hart S; Hartikainen JM; Hartman M; Hassan N; Healey S; Hogervorst FB; Verhoef S; ; Hendricks CB; Hillemanns P; Hollestelle A; Hulick PJ; Hunter DJ; Imyanitov EN; Isaacs C; Ito H; Jakubowska A; Janavicius R; Jaworska-Bieniek K; Jensen UB; John EM; Joly Beauparlant C; Jones M; Kabisch M; Kang D; Karlan BY; Kauppila S; Kerin MJ; Khan S; Khusnutdinova E; Knight JA; Konstantopoulou I; Kraft P; Kwong A; Laitman Y; Lambrechts D; Lazaro C; Le Marchand L; Lee CN; Lee MH; Lester J; Li J; Liljegren A; Lindblom A; Lophatananon A; Lubinski J; Mai PL; Mannermaa A; Manoukian S; Margolin S; Marme F; Matsuo K; McGuffog L; Meindl A; Menegaux F; Montagna M; Muir K; Mulligan AM; Nathanson KL; Neuhausen SL; Nevanlinna H; Newcomb PA; Nord S; Nussbaum RL; Offit K; Olah E; Olopade OI; Olswold C; Osorio A; Papi L; Park-Simon TW; Paulsson-Karlsson Y; Peeters S; Peissel B; Peterlongo P; Peto J; Pfeiler G; Phelan CM; Presneau N; Radice P; Rahman N; Ramus SJ; Rashid MU; Rennert G; Rhiem K; Rudolph A; Salani R; Sangrajrang S; Sawyer EJ; Schmidt MK; Schmutzler RK; Schoemaker MJ; Schürmann P; Seynaeve C; Shen CY; Shrubsole MJ; Shu XO; Sigurdson A; Singer CF; Slager S; Soucy P; Southey M; Steinemann D; Swerdlow A; Szabo CI; Tchatchou S; Teixeira MR; Teo SH; Terry MB; Tessier DC; Teulé A; Thomassen M; Tihomirova L; Tischkowitz M; Toland AE; Tung N; Turnbull C; van den Ouweland AM; van Rensburg EJ; Ven den Berg D; Vijai J; Wang-Gohrke S; Weitzel JN; Whittemore AS; Winqvist R; Wong TY; Wu AH; Yannoukakos D; Yu JC; Pharoah PD; Hall P; Chenevix-Trench G; ; ; Dunning AM; Simard J; Couch FJ; Antoniou AC; Easton DF; Zheng W Breast Cancer Res; 2016 Jun; 18(1):64. PubMed ID: 27459855 [TBL] [Abstract][Full Text] [Related]
16. Correlation between the DNA methylation and gene expression of IGFBP5 in breast cancer. Karabulut S; Kaya Z; Amuran GG; Peker I; Özmen T; Gūllūoḡlu BM; Kaya H; Erzik C; Ōzer A; Akkiprik M Breast Dis; 2016; 36(4):123-131. PubMed ID: 27612043 [TBL] [Abstract][Full Text] [Related]
17. KDM6B Counteracts EZH2-Mediated Suppression of Wang W; Lim KG; Feng M; Bao Y; Lee PL; Cai Y; Chen Y; Zhang H; Marzese D; Hoon DSB; Yu Q Mol Cancer Ther; 2018 Sep; 17(9):1973-1983. PubMed ID: 29925528 [TBL] [Abstract][Full Text] [Related]
18. 2q35-rs13387042 variant and the risk of breast cancer: a case-control study. Nesaei A; Naderi Ghale-Noie Z; Khorshid Shamshiri A; Afzaljavan F; Rivandi M; Tajbakhsh A; Homaei Shandiz F; Pasdar A Mol Biol Rep; 2022 May; 49(5):3549-3557. PubMed ID: 35445312 [TBL] [Abstract][Full Text] [Related]
20. Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population. Elematore I; Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G; Di Capua GA; Jara L Mol Biol Rep; 2014 Jun; 41(6):3715-22. PubMed ID: 24532140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]